<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05620381</url>
  </required_header>
  <id_info>
    <org_study_id>7713</org_study_id>
    <nct_id>NCT05620381</nct_id>
  </id_info>
  <brief_title>Health and Sleep Assessment After the Strasbourg Attacks of December 11, 2018</brief_title>
  <acronym>ELSSA</acronym>
  <official_title>Health and Sleep Assessment After the Strasbourg Attacks of December 11, 2018</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the prevalence of post-traumatic stress disorder (PTSD), associated risk&#xD;
      factors, health care consumption, and sleep disorders in a civilian population exposed to the&#xD;
      December 11, 2018, attacks in Strasbourg. Terrorist attacks have unfortunately become all too&#xD;
      frequent on our territory in recent years. A better knowledge of the psychological and&#xD;
      psychiatric repercussions on exposed populations is essential in order to better prevent and&#xD;
      treat disorders that can have a major functional impact on the lives of exposed individuals&#xD;
      and to adapt care during future similar events&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective evaluation of the prevalence of post-traumatic stress disorder (PTSD) in a population exposed to the attacks of December 11, 2018 in Strasbourg</measure>
    <time_frame>Files analysed retrospectively from February 11, 2018 to November 30, 2019 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stress Disorders, Post-Traumatic</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Major subject (≥ 18 years old) having been exposed to the attacks of December 11, 2018 in&#xD;
        Strasbourg directly or indirectly (presence at the scene or close relative present at the&#xD;
        scene)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Major subject (≥ 18 years old),&#xD;
&#xD;
          -  Having been exposed to the attacks of December 11, 2018 in Strasbourg directly or&#xD;
             indirectly (presence at the scene or close relative present at the scene)&#xD;
&#xD;
          -  Subject who has not expressed his opposition, after information, to the reuse of his&#xD;
             data for the purpose of this research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject who has expressed opposition to participating in the study&#xD;
&#xD;
          -  Subject under guardianship, curatorship or legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Amaury MENGIN, MD</last_name>
    <phone>33 3 88 11 57 70</phone>
    <email>amaury.mengin@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Psychiatrie d'Urgences, de Liaison et de Psychotraumatologie - CHU de Strasbourg - France</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amaury MENGIN, MD</last_name>
      <phone>33 3 88 11 57 70</phone>
      <email>amaury.mengin@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Amaury MENGIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre VIDAILHET, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabrice BERNA, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire BEAUFILS, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Coline BUCHHEIT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cédric PALACIO, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédérique RIEDLIN, Psychologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie ROLLING, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carmen SCHRODER, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>November 9, 2022</last_update_submitted>
  <last_update_submitted_qc>November 9, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stress Disorders</keyword>
  <keyword>Disorders Post-Traumatic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

